Analysis of clinical, dosimetric and radiomic features for predicting local failure after stereotactic radiotherapy of brain metastases in malignant melanoma
Authors:
Nanna E. Hartong,
Ilias Sachpazidis,
Oliver Blanck,
Lucas Etzel,
Jan C. Peeken,
Stephanie E. Combs,
Horst Urbach,
Maxim Zaitsev,
Dimos Baltas,
Ilinca Popp,
Anca-Ligia Grosu,
Tobias Fechter
Abstract:
Background: This study aimed to predict lesion-specific outcomes after stereotactic radiotherapy (SRT) in patients with brain metastases from malignant melanoma (MBM), using clinical, dosimetric pretherapeutic MRI data. Methods: In this multicenter retrospective study, 517 MBM from 130 patients treated with single-fraction or hypofractionated SRT across three centers were analyzed. From contrast-e…
▽ More
Background: This study aimed to predict lesion-specific outcomes after stereotactic radiotherapy (SRT) in patients with brain metastases from malignant melanoma (MBM), using clinical, dosimetric pretherapeutic MRI data. Methods: In this multicenter retrospective study, 517 MBM from 130 patients treated with single-fraction or hypofractionated SRT across three centers were analyzed. From contrast-enhanced T1-weighted MRI, 1576 radiomic features (RF) were extracted per lesion - 788 from the gross tumor volume (GTV), 788 from a 3 mm peritumoral margin. Clinical data, radiation dose and RF from one center were used for feature selection and model development via nested cross-validation; external validation was performed using the other two centers. Results: Local failure occurred in 72 of 517 lesions (13.9%). Predictive models based on clinical data (model 1), RF (model 2), or both (model 3) achieved c-indices of 0.60 +/- 0.15, 0.65 +/- 0.11, and 0.65 +/- 0.12. RF-based models outperformed the clinical model, while dosimetric data alone were not predictive. Most predictive RF came from the peritumoral margin (92%) vs. GTV (76%). On the first external dataset, all models performed similarly (c-index: 0.60-0.63), but showed poor generalization on the second (c-index < 0.50), likely due to differences in patient characteristics and imaging protocols. Conclusions: Information extracted from pretherapeutic MRI, particularly from the peritumoral area, can support accurate prediction of lesion-specific outcomes after SRT in MBM. When combined with clinical data, these imaging-derived markers offer valuable prognostic insights. However, generalizability remains challenging by heterogeneity in patient populations and MRI protocols.
△ Less
Submitted 22 May, 2025; v1 submitted 31 May, 2024;
originally announced May 2024.
The use of deep learning in interventional radiotherapy (brachytherapy): a review with a focus on open source and open data
Authors:
Tobias Fechter,
Ilias Sachpazidis,
Dimos Baltas
Abstract:
Deep learning advanced to one of the most important technologies in almost all medical fields. Especially in areas, related to medical imaging it plays a big role. However, in interventional radiotherapy (brachytherapy) deep learning is still in an early phase. In this review, first, we investigated and scrutinised the role of deep learning in all processes of interventional radiotherapy and direc…
▽ More
Deep learning advanced to one of the most important technologies in almost all medical fields. Especially in areas, related to medical imaging it plays a big role. However, in interventional radiotherapy (brachytherapy) deep learning is still in an early phase. In this review, first, we investigated and scrutinised the role of deep learning in all processes of interventional radiotherapy and directly related fields. Additionally we summarised the most recent developments. To reproduce results of deep learning algorithms both source code and training data must be available. Therefore, a second focus of this work was on the analysis of the availability of open source, open data and open models. In our analysis, we were able to show that deep learning plays already a major role in some areas of interventional radiotherapy, but is still hardly presented in others. Nevertheless, its impact is increasing with the years, partly self-propelled but also influenced by closely related fields. Open source, data and models are growing in number but are still scarce and unevenly distributed among different research groups. The reluctance in publishing code, data and models limits reproducibility and restricts evaluation to mono-institutional datasets. Summarised, deep learning will change positively the workflow of interventional radiotherapy but there is room for improvement when it comes to reproducible results and standardised evaluation methods.
△ Less
Submitted 27 September, 2022; v1 submitted 16 May, 2022;
originally announced May 2022.
